139 related articles for article (PubMed ID: 37628841)
1. Methylation Profile of Small Breast Cancer Tumors Evaluated by Modified MS-HRM.
Krasnyi AM; Sadekova AA; Kometova VV; Rodionov VV; Yarotskaya EL; Sukhikh GT
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628841
[TBL] [Abstract][Full Text] [Related]
2. Automatic Detection of the Circulating Cell-Free Methylated DNA Pattern of
Wang SC; Liao LM; Ansar M; Lin SY; Hsu WW; Su CM; Chung YM; Liu CC; Hung CS; Lin RK
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33803633
[TBL] [Abstract][Full Text] [Related]
3. Identification of differentially methylated genes as diagnostic and prognostic biomarkers of breast cancer.
Mao XH; Ye Q; Zhang GB; Jiang JY; Zhao HY; Shao YF; Ye ZQ; Xuan ZX; Huang P
World J Surg Oncol; 2021 Jan; 19(1):29. PubMed ID: 33499882
[TBL] [Abstract][Full Text] [Related]
4. Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome.
Draht MX; Smits KM; Jooste V; Tournier B; Vervoort M; Ramaekers C; Chapusot C; Weijenberg MP; van Engeland M; Melotte V
Clin Epigenetics; 2016; 8():44. PubMed ID: 27118999
[TBL] [Abstract][Full Text] [Related]
5. MGMT promoter methylation in patients with glioblastoma: is methylation-sensitive high-resolution melting superior to methylation-sensitive polymerase chain reaction assay?
Yamashita S; Yokogami K; Matsumoto F; Saito K; Mizuguchi A; Ohta H; Takeshima H
J Neurosurg; 2018 May; 130(3):780-788. PubMed ID: 29726772
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast.
Huang KT; Dobrovic A; Yan M; Karim RZ; Lee CS; Lakhani SR; Fox SB
Breast Cancer Res Treat; 2010 Nov; 124(2):555-65. PubMed ID: 20563638
[TBL] [Abstract][Full Text] [Related]
7. Quality assessment of DNA derived from up to 30 years old formalin fixed paraffin embedded (FFPE) tissue for PCR-based methylation analysis using SMART-MSP and MS-HRM.
Kristensen LS; Wojdacz TK; Thestrup BB; Wiuf C; Hager H; Hansen LL
BMC Cancer; 2009 Dec; 9():453. PubMed ID: 20025721
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.
Spitzwieser M; Entfellner E; Werner B; Pulverer W; Pfeiler G; Hacker S; Cichna-Markl M
BMC Cancer; 2017 Apr; 17(1):260. PubMed ID: 28403857
[TBL] [Abstract][Full Text] [Related]
9. [Methylation of Runx3 promoter in different breast lesions].
Wang X; Zheng X; Lin X; Shi Y; He Y; Chen G
Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):447-50. PubMed ID: 25327792
[TBL] [Abstract][Full Text] [Related]
10. Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer.
Spitzwieser M; Holzweber E; Pfeiler G; Hacker S; Cichna-Markl M
Breast Cancer Res; 2015 Sep; 17(1):125. PubMed ID: 26370119
[TBL] [Abstract][Full Text] [Related]
11. [GSTP1, APC and RASSF1 gene methylation in prostate cancer samples: comparative analysis of MS-HRM method and Infinium HumanMethylation450 BeadChip beadchiparray diagnostic value].
Skorodumova LO; Babalyan KA; Sultanov R; Vasiliev AO; Govorov AV; Pushkar DY; Prilepskaya EA; Danilenko SA; Generozov EV; Larin AK; Kostryukova ES; Sharova EI
Biomed Khim; 2016 Nov; 62(6):708-714. PubMed ID: 28026816
[TBL] [Abstract][Full Text] [Related]
12. Validation of methylation-sensitive high-resolution melting (MS-HRM) for the detection of stool DNA methylation in colorectal neoplasms.
Xiao Z; Li B; Wang G; Zhu W; Wang Z; Lin J; Xu A; Wang X
Clin Chim Acta; 2014 Apr; 431():154-63. PubMed ID: 24518356
[TBL] [Abstract][Full Text] [Related]
13. Methylation-Sensitive High Resolution Melting (MS-HRM).
Hussmann D; Hansen LL
Methods Mol Biol; 2018; 1708():551-571. PubMed ID: 29224163
[TBL] [Abstract][Full Text] [Related]
14. Methylation levels assessment with Methylation-Sensitive High-Resolution Melting (MS-HRM).
Samsø Mathiasen S; Bińkowski J; Kjeldsen T; Wojdacz TK; Hansen LL
PLoS One; 2022; 17(9):e0273058. PubMed ID: 36067175
[TBL] [Abstract][Full Text] [Related]
15. Detection of
Dong L; Zhu Y; Wu L; Zhang Q; Xu F; Zhang X; Xu X; Tang Y; Ren G; Kang Z; Guan M
J Oncol; 2021; 2021():5514426. PubMed ID: 34759969
[TBL] [Abstract][Full Text] [Related]
16. Assessing combined methylation-sensitive high resolution melting and pyrosequencing for the analysis of heterogeneous DNA methylation.
Candiloro IL; Mikeska T; Dobrovic A
Epigenetics; 2011 Apr; 6(4):500-7. PubMed ID: 21364322
[TBL] [Abstract][Full Text] [Related]
17. Quantitative detection of methylation of FHIT and BRCA1 promoters in the serum of ductal breast cancer patients.
Liu L; Sun L; Li C; Li X; Zhang Y; Yu Y; Xia W
Biomed Mater Eng; 2015; 26 Suppl 1():S2217-22. PubMed ID: 26406001
[TBL] [Abstract][Full Text] [Related]
18. High-resolution melting-based quantitative analysis of RASSF1 methylation in breast cancer.
Stuopelytė K; Daniūnaitė K; Laurinavičienė A; Ostapenko V; Jarmalaitė S
Medicina (Kaunas); 2013; 49(2):78-83. PubMed ID: 23888343
[TBL] [Abstract][Full Text] [Related]
19. [Methylation profiles of genes in breast cancer luminal HER2-negative primary tumor during regional lymphnode metastasis].
Krasnyi AM; Kurevlev SV; Sadekova AA; Sefikhanov TG; Kometova VV; Rodionov VV
Biomed Khim; 2021 Jan; 67(1):88-94. PubMed ID: 33645526
[TBL] [Abstract][Full Text] [Related]
20. Methylation profiling of ductal carcinoma in situ and its relationship to histopathological features.
Pang JM; Deb S; Takano EA; Byrne DJ; Jene N; Boulghourjian A; Holliday A; Millar E; Lee CS; O'Toole SA; Dobrovic A; Fox SB
Breast Cancer Res; 2014 Oct; 16(5):423. PubMed ID: 25331261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
